Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.

Strazzabosco M, Cortesi PA, Conti S, Okolicsanyi S, Rota M, Ciaccio A, Cozzolino P, Fornari C, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Zavaglia C, Perricone G, Munari LM, Mantovani LG, Belli LS.

Liver Int. 2019 Oct 26. doi: 10.1111/liv.14285. [Epub ahead of print]

PMID:
31654608
2.

Colloidal plasmonic nanostar antennas with wide range resonance tunability.

Tsoulos TV, Atta S, Lagos MJ, Beetz M, Batson PE, Tsilomelekis G, Fabris L.

Nanoscale. 2019 Oct 28;11(40):18662-18671. doi: 10.1039/c9nr06533d. Epub 2019 Oct 4.

PMID:
31584591
3.

Impact of Protein Corona in Nanoflare-Based Biomolecular Detection and Quantification.

Wang H, Dardir K, Lee KB, Fabris L.

Bioconjug Chem. 2019 Oct 16;30(10):2555-2562. doi: 10.1021/acs.bioconjchem.9b00495. Epub 2019 Sep 13.

PMID:
31479244
4.

Present and Future of Surface-Enhanced Raman Scattering.

Langer J, Jimenez de Aberasturi D, Aizpurua J, Alvarez-Puebla RA, Auguié B, Baumberg JJ, Bazan GC, Bell SEJ, Boisen A, Brolo AG, Choo J, Cialla-May D, Deckert V, Fabris L, Faulds K, García de Abajo FJ, Goodacre R, Graham D, Haes AJ, Haynes CL, Huck C, Itoh T, Käll M, Kneipp J, Kotov NA, Kuang H, Le Ru EC, Lee HK, Li JF, Ling XY, Maier SA, Mayerhöfer T, Moskovits M, Murakoshi K, Nam JM, Nie S, Ozaki Y, Pastoriza-Santos I, Perez-Juste J, Popp J, Pucci A, Reich S, Ren B, Schatz GC, Shegai T, Schlücker S, Tay LL, Thomas KG, Tian ZQ, Van Duyne RP, Vo-Dinh T, Wang Y, Willets KA, Xu C, Xu H, Xu Y, Yamamoto YS, Zhao B, Liz-Marzán LM.

ACS Nano. 2019 Oct 8. doi: 10.1021/acsnano.9b04224. [Epub ahead of print]

PMID:
31478375
5.

Cell Interactions in Biliary Diseases: Clues from Pathophysiology and Repair Mechanisms to Foster Early Assessment.

Fabris L, Spirli C, Mertens J.

Int J Mol Sci. 2019 Aug 14;20(16). pii: E3961. doi: 10.3390/ijms20163961.

6.

Identification and quantification of gold engineered nanomaterials and impaired fluid transfer across the rat placenta via ex vivo perfusion.

D'Errico JN, Doherty C, Fournier SB, Renkel N, Kallontzi S, Goedken M, Fabris L, Buckley B, Stapleton PA.

Biomed Pharmacother. 2019 Sep;117:109148. doi: 10.1016/j.biopha.2019.109148. Epub 2019 Jul 4.

7.

Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.

Kyritsi K, Chen L, O'Brien A, Francis H, Hein TW, Venter J, Wu N, Ceci L, Zhou T, Zawieja D, Gashev AA, Meng F, Invernizzi P, Fabris L, Wu C, Skill NJ, Saxena R, Liangpunsakul S, Alpini G, Glaser SS.

Hepatology. 2019 Jul 25. doi: 10.1002/hep.30880. [Epub ahead of print]

PMID:
31344280
8.

Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.

Kennedy L, Francis H, Invernizzi P, Venter J, Wu N, Carbone M, Gershwin ME, Bernuzzi F, Franchitto A, Alvaro D, Marzioni M, Onori P, Gaudio E, Sybenga A, Fabris L, Meng F, Glaser S, Alpini G.

FASEB J. 2019 Sep;33(9):10269-10279. doi: 10.1096/fj.201802606R. Epub 2019 Jun 28.

PMID:
31251081
9.

Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Fabris L, Fiorotto R, Spirli C, Cadamuro M, Mariotti V, Perugorria MJ, Banales JM, Strazzabosco M.

Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):497-511. doi: 10.1038/s41575-019-0156-4. Review.

10.

Theory of hot electrons: general discussion.

Aizpurua J, Baletto F, Baumberg J, Christopher P, Nijs B, Deshpande P, Diaz Fernandez Y, Fabris L, Freakley S, Gawinkowski S, Govorov A, Halas N, Hernandez R, Jankiewicz B, Khurgin J, Kuisma M, Kumar PV, Lischner J, Liu J, Marini A, Maurer RJ, Mueller NS, Parente M, Park JY, Reich S, Sivan Y, Tagliabue G, Torrente-Murciano L, Thangamuthu M, Xiao X, Zayats A.

Faraday Discuss. 2019 May 23;214(0):245-281. doi: 10.1039/c9fd90012h. No abstract available.

PMID:
31095152
11.

New materials for hot electron generation: general discussion.

Aizpurua J, Baumberg J, Boltasseva A, Christopher P, Cortes E, Cronin SB, Dadhich BK, de Nijs B, Deshpande P, Diaz Fernandez Y, Fabris L, Gawinkowski S, Govorov A, Halas N, Huang J, Jankiewicz B, Kamarudheen R, Khurgin J, Lee TK, Mahin J, Marini A, Maurer RJ, Mueller NS, Park JY, Rahaman M, Schlücker S, Schultz Z, Sivan Y, Tagliabue G, Thangamuthu M, Xu H, Zayats A.

Faraday Discuss. 2019 May 1;214:365-386. doi: 10.1039/c9fd90013f. Epub 2019 May 15. No abstract available.

PMID:
31090770
12.

Applications in catalysis, photochemistry, and photodetection: general discussion.

Aizpurua J, Baumberg J, Caps V, Cortes E, de Nijs B, Diaz Fernandez Y, Fabris L, Freakley S, Gawinkowski S, Glass D, Huang J, Jankiewicz B, Khurgin J, Kumar PV, Maurer RJ, McBreen P, Mueller NS, Park JY, Quiroz J, Rejman S, Romero Gómez RM, Salmon-Gamboa J, Schlücker S, Schultz Z, Shukla A, Sivan Y, Thangamuthu M, Torrente-Murciano L, Xiao X, Xu H, Zhan C.

Faraday Discuss. 2019 May 1;214:479-499. doi: 10.1039/c9fd90014d. Epub 2019 May 15. No abstract available.

PMID:
31089633
13.

A Review on Surface-Enhanced Raman Scattering.

Pilot R, Signorini R, Durante C, Orian L, Bhamidipati M, Fabris L.

Biosensors (Basel). 2019 Apr 17;9(2). pii: E57. doi: 10.3390/bios9020057. Review.

14.

The tumour microenvironment and immune milieu of cholangiocarcinoma.

Fabris L, Perugorria MJ, Mertens J, Björkström NK, Cramer T, Lleo A, Solinas A, Sänger H, Lukacs-Kornek V, Moncsek A, Siebenhüner A, Strazzabosco M.

Liver Int. 2019 May;39 Suppl 1:63-78. doi: 10.1111/liv.14098. Review.

PMID:
30907492
15.

Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.

Chen L, Zhou T, Wu N, O'Brien A, Venter J, Ceci L, Kyritsi K, Onori P, Gaudio E, Sybenga A, Xie L, Wu C, Fabris L, Invernizzi P, Zawieja D, Liangpunsakul S, Meng F, Francis H, Alpini G, Huang Q, Glaser S.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1525-1539. doi: 10.1016/j.bbadis.2019.03.002. Epub 2019 Mar 16.

PMID:
30890428
16.

Enhancing hot electron generation and injection in the near infrared via rational design and controlled synthesis of TiO2-gold nanostructures.

Atta S, Celik FE, Fabris L.

Faraday Discuss. 2019 May 23;214(0):341-351. doi: 10.1039/c8fd00152a.

PMID:
30843543
17.

Incretin-based treatment in type 2 diabetes mellitus and risk of cholangiocarcinoma: Is it only adverse drug effect?

Barbato GM, Cadamuro M, Fabris L.

Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):232-235. doi: 10.1016/j.clinre.2019.01.009. Epub 2019 Mar 1. No abstract available.

PMID:
30833185
18.

Effect of Gestational Age on Maternofetal Vascular Function Following Single Maternal Engineered Nanoparticle Exposure.

Fournier SB, Kallontzi S, Fabris L, Love C, Stapleton PA.

Cardiovasc Toxicol. 2019 Aug;19(4):321-333. doi: 10.1007/s12012-019-09505-0.

19.

Understanding the role of AgNO3 concentration and seed morphology in the achievement of tunable shape control in gold nanostars.

Atta S, Beetz M, Fabris L.

Nanoscale. 2019 Feb 7;11(6):2946-2958. doi: 10.1039/c8nr07615d.

PMID:
30693922
20.

Endo-laparoscopic reconstruction of the abdominal wall midline with linear stapler, the THT technique. Early results of the first case series.

Carrara A, Lauro E, Fabris L, Frisini M, Rizzo S.

Ann Med Surg (Lond). 2018 Dec 12;38:1-7. doi: 10.1016/j.amsu.2018.12.002. eCollection 2019 Feb.

21.

Improved Precision in Surface-Enhanced Raman Scattering Quantification of Analyte through Dual-Modality Multisite Sensing.

Sardar S, Fabris L, Javanmard M.

Anal Chem. 2019 Apr 2;91(7):4323-4330. doi: 10.1021/acs.analchem.8b02559. Epub 2019 Feb 8.

PMID:
30561991
22.

Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.

Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, Fingas C, Cristina Malerba M, Nardo G, Dall'Olmo L, Milani E, Mariotti V, Stecca T, Massani M, Spirli C, Fiorotto R, Indraccolo S, Strazzabosco M, Fabris L.

J Hepatol. 2019 Apr;70(4):700-709. doi: 10.1016/j.jhep.2018.12.004. Epub 2018 Dec 14.

PMID:
30553841
23.

Animal models of cholestasis: An update on inflammatory cholangiopathies.

Mariotti V, Cadamuro M, Spirli C, Fiorotto R, Strazzabosco M, Fabris L.

Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):954-964. doi: 10.1016/j.bbadis.2018.07.025. Epub 2018 Aug 11. Review.

PMID:
30398152
24.

Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.

Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M.

Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):920-928. doi: 10.1016/j.bbadis.2018.08.038. Epub 2018 Sep 5. Review.

25.

Precision medicine in cholangiocarcinoma.

Pellino A, Loupakis F, Cadamuro M, Dadduzio V, Fassan M, Guido M, Cillo U, Indraccolo S, Fabris L.

Transl Gastroenterol Hepatol. 2018 Jul 12;3:40. doi: 10.21037/tgh.2018.07.02. eCollection 2018. Review.

26.

SERS-Based Quantification of Biomarker Expression at the Single Cell Level Enabled by Gold Nanostars and Truncated Aptamers.

Bhamidipati M, Cho HY, Lee KB, Fabris L.

Bioconjug Chem. 2018 Sep 19;29(9):2970-2981. doi: 10.1021/acs.bioconjchem.8b00397. Epub 2018 Aug 24.

PMID:
30110153
27.

Animal models for cystic fibrosis liver disease (CFLD).

Fiorotto R, Amenduni M, Mariotti V, Cadamuro M, Fabris L, Spirli C, Strazzabosco M.

Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):965-969. doi: 10.1016/j.bbadis.2018.07.026. Epub 2018 Jul 30. Review.

PMID:
30071276
28.

Animal models of cholangiocarcinoma: What they teach us about the human disease.

Cadamuro M, Brivio S, Stecca T, Kaffe E, Mariotti V, Milani C, Fiorotto R, Spirli C, Strazzabosco M, Fabris L.

Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):403-415. doi: 10.1016/j.clinre.2018.04.008. Epub 2018 May 9. Review.

PMID:
29753731
29.

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.

Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA.

Genome Res. 2018 Apr;28(4):432-447. doi: 10.1101/gr.225128.117. Epub 2018 Mar 22.

30.

Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.

Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M.

Nat Commun. 2018 Jan 8;9(1):160. doi: 10.1038/s41467-017-02485-1.

31.

Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.

Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M.

Nat Commun. 2017 Nov 27;8(1):1801. doi: 10.1038/s41467-017-01562-9. Erratum in: Nat Commun. 2018 Jan 8;9(1):160.

32.

β-Catenin and interleukin-1β-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis.

Kaffe E, Fiorotto R, Pellegrino F, Mariotti V, Amenduni M, Cadamuro M, Fabris L, Strazzabosco M, Spirli C.

Hepatology. 2018 May;67(5):1903-1919. doi: 10.1002/hep.29652. Epub 2018 Mar 25.

33.

Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Brivio S, Cadamuro M, Fabris L, Strazzabosco M.

Gene Expr. 2018 Mar 21;18(1):31-50. doi: 10.3727/105221617X15088670121925. Epub 2017 Oct 25. Review.

34.

Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine.

Carbone M, Cristoferi L, Cortesi PA, Rota M, Ciaccio A, Okolicsanyi S, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Belli LS, Munari LM, Mantovani L, Strazzabosco M.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1415-1422. doi: 10.1016/j.bbadis.2017.08.025. Epub 2017 Aug 24.

35.

Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.

Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M.

Hepatology. 2018 Mar;67(3):972-988. doi: 10.1002/hep.29400. Epub 2018 Jan 26.

36.

Observation of coherent elastic neutrino-nucleus scattering.

Akimov D, Albert JB, An P, Awe C, Barbeau PS, Becker B, Belov V, Brown A, Bolozdynya A, Cabrera-Palmer B, Cervantes M, Collar JI, Cooper RJ, Cooper RL, Cuesta C, Dean DJ, Detwiler JA, Eberhardt A, Efremenko Y, Elliott SR, Erkela EM, Fabris L, Febbraro M, Fields NE, Fox W, Fu Z, Galindo-Uribarri A, Green MP, Hai M, Heath MR, Hedges S, Hornback D, Hossbach TW, Iverson EB, Kaufman LJ, Ki S, Klein SR, Khromov A, Konovalov A, Kremer M, Kumpan A, Leadbetter C, Li L, Lu W, Mann K, Markoff DM, Miller K, Moreno H, Mueller PE, Newby J, Orrell JL, Overman CT, Parno DS, Penttila S, Perumpilly G, Ray H, Raybern J, Reyna D, Rich GC, Rimal D, Rudik D, Scholberg K, Scholz BJ, Sinev G, Snow WM, Sosnovtsev V, Shakirov A, Suchyta S, Suh B, Tayloe R, Thornton RT, Tolstukhin I, Vanderwerp J, Varner RL, Virtue CJ, Wan Z, Yoo J, Yu CH, Zawada A, Zettlemoyer J, Zderic AM; COHERENT Collaboration.

Science. 2017 Sep 15;357(6356):1123-1126. doi: 10.1126/science.aao0990. Epub 2017 Aug 3.

PMID:
28775215
37.

The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.

Cadamuro M, Stecca T, Brivio S, Mariotti V, Fiorotto R, Spirli C, Strazzabosco M, Fabris L.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1435-1443. doi: 10.1016/j.bbadis.2017.07.028. Epub 2017 Jul 27. Review.

38.

Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.

Strazzabosco M, Fiorotto R, Cadamuro M, Spirli C, Mariotti V, Kaffe E, Scirpo R, Fabris L.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1374-1379. doi: 10.1016/j.bbadis.2017.07.023. Epub 2017 Jul 25. Review.

39.

Understanding the Genomic Ultraconservations: T-UCRs and Cancer.

Fabris L, Calin GA.

Int Rev Cell Mol Biol. 2017;333:159-172. doi: 10.1016/bs.ircmb.2017.04.004. Epub 2017 Jun 7. Review.

PMID:
28729024
40.

Animal models of biliary injury and altered bile acid metabolism.

Mariotti V, Strazzabosco M, Fabris L, Calvisi DF.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1254-1261. doi: 10.1016/j.bbadis.2017.06.027. Epub 2017 Jul 11. Review.

41.

Hydraulic modelling of the spatial and temporal variability in Atlantic salmon parr habitat availability in an upland stream.

Fabris L, Malcolm IA, Buddendorf WB, Millidine KJ, Tetzlaff D, Soulsby C.

Sci Total Environ. 2017 Dec 1;601-602:1046-1059. doi: 10.1016/j.scitotenv.2017.05.112. Epub 2017 Jun 9.

PMID:
28599361
42.

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.

Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA.

Genome Biol. 2017 May 24;18(1):98. doi: 10.1186/s13059-017-1224-0.

43.

Emerging concepts in biliary repair and fibrosis.

Fabris L, Spirli C, Cadamuro M, Fiorotto R, Strazzabosco M.

Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G102-G116. doi: 10.1152/ajpgi.00452.2016. Epub 2017 May 19. Review.

44.

Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.

Brivio S, Cadamuro M, Strazzabosco M, Fabris L.

World J Hepatol. 2017 Mar 28;9(9):455-468. doi: 10.4254/wjh.v9.i9.455.

45.

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group.

Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6.

46.

A closer look at the physical and optical properties of gold nanostars: an experimental and computational study.

Tsoulos TV, Han L, Weir J, Xin HL, Fabris L.

Nanoscale. 2017 Mar 17;9(11):3766-3773. doi: 10.1039/c6nr09091e.

PMID:
28267160
47.

p27kip1: An all-round tumor suppressor.

Belletti B, Fabris L, Baldassarre G.

Mol Cell Oncol. 2016 Feb 18;3(5):e1141742. doi: 10.1080/23723556.2016.1141742. eCollection 2016.

48.

Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.

Cadamuro M, Brivio S, Spirli C, Joplin RE, Strazzabosco M, Fabris L.

Int J Mol Sci. 2017 Jan 13;18(1). pii: E149. doi: 10.3390/ijms18010149. Review.

49.

Multiparametric Assessment of Gold Nanoparticle Cytotoxicity in Cancerous and Healthy Cells: The Role of Size, Shape, and Surface Chemistry.

Bhamidipati M, Fabris L.

Bioconjug Chem. 2017 Feb 15;28(2):449-460. doi: 10.1021/acs.bioconjchem.6b00605. Epub 2017 Jan 6.

PMID:
27992181
50.

Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.

Spirli C, Mariotti V, Villani A, Fabris L, Fiorotto R, Strazzabosco M.

J Hepatol. 2017 Mar;66(3):571-580. doi: 10.1016/j.jhep.2016.10.032. Epub 2016 Nov 5.

Supplemental Content

Loading ...
Support Center